Avicella Capital

🇦🇺 This Week in Australian Startups #179, 26th September 2026

Weekly roundup recording a dozen raises and acquisitions, Firmus's scheduled float, a new $50m venture fund, a founder share sale, grant winners, an accelerator intake, and an AI agent's government breach.

Also DealStreetAsia·Dealroom·This Week in Australian Startups·AFR Technology·AFR Technology·Startup Daily·AFR Technology·AFR Technology·ABC News Technology·iTnews

Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top

Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.

Manufacturing news briefs — stories you might have missed

Roundup of short industry items: Element 25 and Vaxxas win US government grants, Orthocell gets an R&D refund, Convergence Medical completes its Series A, and Monique Conheady takes a Hysata board seat.

Also Startup Daily

Three Aussie startups that raised $46.5 million this week

Roundup of three Australian raises — ElectraLith, Coposit and Convergence Medical — plus Quantum Brilliance naming its Series A backers and Rokt's secondary share sale.

Brisbane robotics surgery startup operates on $5 million Series A

Brisbane arthroscopic robotics maker Convergence Medical has raised a $5 million Series A from US backer Avicella Capital at a valuation topping $30 million, to commercialise its V01 robot in the US.

Also SmartCompany·@AuManufacturing·@AuManufacturing·podtail.nl·@AuManufacturing

Arthroscopic robot developer Convergence Medical seals $5m Series A, boosting its valuation to $30m

Brisbane medtech Convergence Medical has closed a $5 million Series A with US backer Avicella Capital, valuing the surgical robot developer at $30 million as it prepares to commercialise and enter the US market.

Convergence Medical secure $5 million from global investors for world-first surgical robot

Brisbane surgical robotics company Convergence Medical has closed its Series A at AU$5 million from US backer Avicella Capital, valuing it above AU$30 million as it prepares to commercialise its arthroscopic robot VO1.

Five ANZ startups that raised $38.5 million this week

Weekly roundup detailing five raises across Australian and New Zealand startups — Hapana, Kinoxis Therapeutics, Appetise, Bike Matrix and Aglow — worth a combined $38.5 million, naming lead investors and planned expansion for each.

Also SmartCompany·Startup Daily

Kinoxis secures $14.5m in funding and announces expansion of clinical programs to target agitation and aggression in dementia patients

Australian biotech Kinoxis Therapeutics raised $14.5 million in Series B backing from Uniseed, UniSuper and others to fund Phase 2 trials of KNX100 for dementia-related agitation, including a new Australian study.

Also SmartCompany·Startup Daily·Startup Daily